Patrícia Scuracchio
YOU?
Author Swipe
View article: International Forum on Management of Blood Donors with Culture‐Positive Platelet Donations: Summary
International Forum on Management of Blood Donors with Culture‐Positive Platelet Donations: Summary Open
View article: The 4-Year Experience with Implementation and Routine Use of Pathogen Reduction in a Brazilian Hospital
The 4-Year Experience with Implementation and Routine Use of Pathogen Reduction in a Brazilian Hospital Open
(1) Background: We reviewed the logistics of the implementation of pathogen reduction (PR) using the INTERCEPT Blood System™ for platelets and the experience with routine use and clinical outcomes in the patient population at the Sírio-Lib…
View article: The 4-Year Experience with Implementation and Routine Use of Pathogen Inactivation in a Brazilian Hospital
The 4-Year Experience with Implementation and Routine Use of Pathogen Inactivation in a Brazilian Hospital Open
(1) Background: We reviewed the logistics of the implementation of pathogen inactivation (PI) using the INTERCEPT Blood System™ for platelets and the experience with routine use and clinical outcomes in the patient population at the …
View article: Surrogate test performance for <scp>SARS‐CoV</scp>‐2 neutralizing antibodies (<scp>nAbs</scp>) for convalescent plasma (<scp>CCP</scp>): How useful could they be?
Surrogate test performance for <span>SARS‐CoV</span>‐2 neutralizing antibodies (<span>nAbs</span>) for convalescent plasma (<span>CCP</span>): How useful could they be? Open
Background COVID‐19 high‐titer CCP selection is a concern, because neutralizing antibody (nAb) testing requires sophisticated labs and methods. Surrogate tests are an alternative for measuring nAb levels in plasma bags, including those tha…
View article: UTILIZAÇÃO DO PLASMA FRESCO CONVALESCENTE EM PACIENTES DE ALTO RISCO DURANTE FASES PRECOCES DE INFECÇÃO POR COVID-19
UTILIZAÇÃO DO PLASMA FRESCO CONVALESCENTE EM PACIENTES DE ALTO RISCO DURANTE FASES PRECOCES DE INFECÇÃO POR COVID-19 Open
View article: <scp>COVID</scp>‐19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes
<span>COVID</span>‐19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes Open
Background Current evidence regarding COVID‐19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing …
View article: International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Responses
International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Responses Open
Vox SanguinisVolume 116, Issue 10 p. e71-e120 International Forum International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Responses Arwa Z. Al-Riyami, Arwa Z. Al-Riyami [email protected] orcid.org/0000-0001-8649-0650…
View article: International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary
International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary Open
Coronavirus disease-2019 (COVID-19), caused by severe acute respiratory coronavirus 2(SARS-CoV-2), has rapidly spread since its first declaration by the World Health Organization (WHO) as a global pandemic in March 2020 [1]. Until vaccinat…
View article: Anti‐A and SARS‐CoV‐2: an intriguing association
Anti‐A and SARS‐CoV‐2: an intriguing association Open
Background Blood groups and anti‐A isohemagglutinin may be involved in susceptibility to SARS‐CoV‐2 infection. Materials and Methods We retrospectively studied 268 COVID‐19 convalescent plasma donors and 162 COVID‐19 inpatients (total 430 …
View article: A longitudinal study of convalescent plasma ( <scp>CCP</scp> ) donors and correlation of <scp>ABO</scp> group, initial neutralizing antibodies ( <scp>nAb</scp> ), and body mass index ( <scp>BMI</scp> ) with <scp>nAb</scp> and anti‐nucleocapsid ( <scp>NP</scp> ) <scp>SARS‐CoV</scp> ‐2 antibody kinetics: Proposals for better quality of <scp>CCP</scp> collections
A longitudinal study of convalescent plasma ( <span>CCP</span> ) donors and correlation of <span>ABO</span> group, initial neutralizing antibodies ( <span>nAb</span> ), and body mass index ( <span>BMI</span> ) with <span>nAb</span> and anti‐nucleocapsid ( <span>NP</span> ) <span>SARS‐CoV</span> ‐2 antibody kinetics: Proposals for better quality of <span>CCP</span> collections Open
Introduction Little is known about the neutralizing (nAb) and binding antibody kinetics in COVID‐19 convalescent plasma donors, especially during the first 100 days after disease onset. Materials and Methods A cohort of previously RT‐PCR p…
View article: Impact of Convalescent Plasma Transfusion (CCP) In Patients With Previous Circulating Neutralizing Antibodies (nAb) to COVID-19
Impact of Convalescent Plasma Transfusion (CCP) In Patients With Previous Circulating Neutralizing Antibodies (nAb) to COVID-19 Open
INTRODUCTION COVID-19 convalescent plasma (CCP) transfusion has emerged in the past months as an alternative approach to treat pneumonia cases of SARS-CoV-2. Current evidence regarding characteristics of the plasma product, the titer of ne…
View article: Correlation of Body Mass Index (BMI), initial neutralizing antibodies (nAb), ABO group and kinetics of nAb and anti-nucleocapsid (NP) SARS-CoV-2 antibodies in convalescent plasma (CCP) donors – A longitudinal study with proposals for better quality of CCP collections
Correlation of Body Mass Index (BMI), initial neutralizing antibodies (nAb), ABO group and kinetics of nAb and anti-nucleocapsid (NP) SARS-CoV-2 antibodies in convalescent plasma (CCP) donors – A longitudinal study with proposals for better quality of CCP collections Open
Introduction A cohort of COVID-19 convalescent volunteers allowed the study of neutralizing (nAb) and ligand antibodies kinetics by providing sequential samples during a median of 100 days after onset of disease. Material and Methods A coh…
View article: CINÉTICA DE ANTICORPOS NEUTRALIZANTES (NAB) E DE LIGAÇÃO CONTRA ANTÍGENOS NUCLEOCAPSÍDEOS (NP) DE SARS-CoV-2 EM DOADORES DE PLASMA CONVALESCENTE (CCP)
CINÉTICA DE ANTICORPOS NEUTRALIZANTES (NAB) E DE LIGAÇÃO CONTRA ANTÍGENOS NUCLEOCAPSÍDEOS (NP) DE SARS-CoV-2 EM DOADORES DE PLASMA CONVALESCENTE (CCP) Open
View article: ANTI-A AND SARS-COV-2: AN INTRIGUING ASSOCIATION
ANTI-A AND SARS-COV-2: AN INTRIGUING ASSOCIATION Open
View article: Screening for <scp>SARS‐CoV</scp>‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program
Screening for <span>SARS‐CoV</span>‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program Open
Background Coronavirus disease 2019 (COVID‐19) convalescent plasma (CCP) collection began in two Brazilian hospitals for treatment of severe/critical patients. Methods and Materials Mild/moderate COVID‐19 convalescents were selected as CCP…